Industries > Pharma > Global Overactive Bladder Treatment Market 2018-2028

Back to Pharma Reports

Global Overactive Bladder Treatment Market 2018-2028

Prescription Drugs, OTC Drugs, Short-term Therapy, Long-term Therapy

PUBLISHED: 25 May 2018

PAGES: 161

PRODUCT CODE: PHA0311

SUBMARKET: Medical Devices Therapeutic Drugs

SKU: PHA0311 Categories: Medical Devices, Pharma, Therapeutic Drugs Tag: PHA0344

The global overactive bladder treatment market is expected to grow at a CAGR of 2.4% in the first half of the forecast period. In 2017, the prescription drugs segment held 96% of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 161-page report you will receive 136 charts– all unavailable elsewhere.

The 161-page report provides clear detailed insight into the global overactive bladder treatment market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Overactive Bladder Treatment market forecasts from 2018-2028

• This report also breaks down the revenue forecast for the global overactive bladder treatment market by these submarkets:
• Prescription Drugs Market Forecast 2018-2028
• OTC Drugs Market Forecast 2018-2028
• Short-term Therapy Market Forecast 2018-2028
• Long-term Therapy Market Forecast 2018-2028

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• US
• EU5: Germany, France, UK, Italy, Spain
• BRIC: Brazil, Russia, India, China
• Japan
• RoW: South Korea, Australia, Canada, MENA, Others

• Our study gives qualitative analysis of the overactive bladder treatment market:
• Drivers and Restraints
• Porter’s Five Forces Analysis
• SWOT Analysis
• Trends and Opportunities
• Reimbursement scenarios in the US, Europe and Japan

• Our study discusses the selected leading companies that are the major players in the overactive bladder treatment market:
• Allergan
• Apotex
• Astellas
• Medtronic
• Mylan
• Pfizer
• Sanofi

Visiongain’s study is intended for anyone requiring commercial analyses for the global overactive bladder treatment market. You find data, trends and predictions.

Buy our report today Global Overactive Bladder Treatment Market 2018-2028: Prescription Drugs, OTC Drugs, Short-term Therapy, Long-term Therapy.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Why You Should Read This Report

1.2 How This Report Delivers

1.3 Key Questions Answered by This Analytical Report Include:

1.4 Who is This Report For?

1.5 Methodology

1.5.1 Primary Research

1.5.2 Secondary Research

1.5.3 Market Evaluation & Forecasting Methodology

1.6 Frequently Asked Questions (FAQ)

1.7 Associated Visiongain Reports

1.8 About Visiongain

2. Introduction to Overactive Bladder

2.1 Available Diagnosis for Overactive Bladder Symptoms

2.1.1 Urinalysis

2.1.2 Urodynamic Tests

2.1.3 Uroflowmetry

2.1.4 Cough Stress Test

2.1.5 Prostate or Pelvic exam

2.1.6 Cystourethrogram

2.2 Class of Drugs

2.2.1 Anti-muscarinic Agent

2.2.2 Beta-3-Adrenergic Receptor Agonist

2.3 Available Treatments for Overactive Bladder

2.3.1 Behavioural Therapy

2.3.2 Pelvic Floor Physiotherapy

2.3.3 Electrical Stimulation

2.4 The Prevalence and Burden of Overactive Bladder

2.5 Drug Profiles

2.5.1 Darifenacin

2.5.2 Fesoterodine

2.5.3 Worldwide Sales of Toviaz 2016 vs 2017

2.5.4 Oxybutynin

2.5.5 Solifenacin

2.5.6 Tolterodine

2.5.7 Trospium

2.5.8 Botox Injection

3. Global Overactive Bladder Therapeutic Market Forecast 2018-2028

4. Global Overactive Bladder Therapeutic Market 2018-2028: Submarket Segmentation by Prescription and OTC Drugs

4.1 Forecast by Prescription vs OTC Drugs 2018-2028

4.1.1 Global Overactive Bladder Prescription Drugs Market 2018-2028

4.1.2 Global Overactive Bladder OTC Drugs Market 2018-2028

4.1.3 Market Share Forecast - Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2018-2028

5. Global Overactive Bladder Therapeutic Market 2018-2028: Submarket Segmentation by Duration of Therapy 2018-2028

5.1 Forecast by Duration of Therapy 2018-2028

5.2 Global Overactive Short-term Overactive Bladder Therapy Market 2018-2028

5.3 Global Overactive Bladder Long-term Therapy Market 2018-2028

5.4 Market Share Forecast by Duration of Therapy 2018-2028

6. Global Overactive Bladder Therapeutic Market: Drivers, Restraints and Trends

7. Global Overactive Bladder Therapeutic Market 2018-2028: Leading National Markets

7.1 Geographical Breakdown of Global Overactive Bladder Therapeutic Market, 2017

7.1.1 Breakdown of Global Overactive Bladder Therapeutic Market by Region, 2017

7.1.2 Breakdown of Global Overactive Bladder Therapeutic Market by Country, 2017

7.1.3 Region-wise Forecast of Global Overactive Bladder Therapeutic Market, 2018-2028

7.2 Global Overactive Bladder Therapeutic Market in the US, 2017

7.2.1 Healthcare Scenario in the US

7.2.2 Economic Impacts of Overactive Bladder

7.2.3 US Overactive Bladder Therapeutic Market 2018-2028

7.3 EU5 Overactive Bladder Therapeutic Market 2018-2028

7.3.1 The UK Overactive Bladder Therapeutic Market 2018-2028

7.3.2 Germany Overactive Bladder Therapeutic Market 2018-2028

7.3.3 France Overactive Bladder Therapeutic Market 2018-2028

7.3.4 Italy Overactive Bladder Therapeutic Market 2018-2028

7.3.5 Spain Overactive Bladder Therapeutic Market 2018-2028

7.4 BRIC Overactive Bladder Therapeutic Market 2018-2028

7.4.1 Brazil Overactive Bladder Therapeutic Market 2018-2028

7.4.2 Russia Overactive Bladder Therapeutic Market 2018-2028

7.4.3 China Overactive Bladder Therapeutic Market 2018-2028

7.4.4 India Overactive Bladder Therapeutic Market 2018-2028

7.5 Japan Overactive Bladder Therapeutic Market 2018-2028

7.6 Australia Overactive Bladder Therapeutic Market 2018-2028

7.7 Canada Overactive Bladder Therapeutic Market 2018-2028

8. Global Overactive Bladder Therapeutic Market: Leading Companies

8.1 Competitive Scenarios

8.2 Astellas

8.3 Pfizer

8.4 Allergan

8.5 Sanofi

8.6 Medtronic

8.7 Apotex

8.8 Mylan

9. Drugs to Treat Overactive Bladder

10. Global Overactive Bladder Therapeutic Market: Qualitative Analysis

10.1 SWOT Analysis

10.2 Porter’s Five Forces Analysis

10.3 Overall Global Overactive Bladder Therapeutic Market Drivers

10.3.1 Number of Elderly Patients Expected to Rise

10.3.2 Opportunities from the Long Pipeline Will Drive Growth

10.3.3 Focus on early diagnosis will increase the number of patients in the market

10.4 Restraints on Growth in the Overactive Bladder Therapeutic Market

10.4.1 Low Awareness

10.4.2 Competition from Generics Will Increase

10.4.3 High Number of Products Will Saturate Market

10.4.4 Lack of reimbursement for Diagnosis and therapeutic products will hinder the market growth

10.5 Opportunities on Growth in the Overactive Bladder Therapeutic Market

10.5.1 Need for Effective Drugs with Better Safety Profiles

10.6 Reimbursement

10.6.1 NICE (UK)

10.6.2 SMC (Scotland)

10.6.3 PBAC (Australia)

10.6.4 CADTH (Canada)

10.6.5 G-BA (Germany)

10.6.6 HAS (France)

10.7 Reimbursement Scenarios in various Countries

10.7.1 Japan

10.7.2 The US

10.7.3 Europe

11. Overactive Bladder Therapeutic Market: Other Prominent Vendors

12. Conclusion

Appendices

Associated Visiongain Reports

Visiongain Report Sales Order Form

About Visiongain

Visiongain report evaluation form

List of Tables

Table 3.1 Global Overactive Bladder Therapeutic Market Forecast 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 4.1 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 4.2 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs 2017-2028: AGR (%)

Table 4.3 Global Overactive Bladder Prescription Drugs Market 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 4.4 Global Overactive Bladder OTC Drugs Market 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 4.5 Global Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2018-2028: Market Share (%)

Table 5.1 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 5.2 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy 2017-2028: AGR (%)

Table 5.3 Global Overactive Bladder Short-term Therapy Market 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 5.4 Global Overactive Bladder Long-term Therapy Market 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 5.5 Global Overactive Bladder Therapeutic Market by Duration of Therapy 2017-2028: Market Share Forecast 2018-2028 (%)

Table 7.1 Global Overactive Bladder Therapeutic Market by Region: Revenue ($m), and Market Share (%), 2017

Table 7.2 Global Overactive Bladder Therapeutic Market by Country: Revenue ($m), and Market Share (%), 2017

Table 7.3 Global Overactive Bladder Therapeutic Market Forecast by Region: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.4 Global Overactive Bladder Therapeutic Market by Region: AGR 2017-2028 (%)

Table 7.5 Global Overactive Bladder Therapeutic Market Forecast 2017-2028: AGR (%)

Table 7.6 Overactive Bladder Therapeutic Market Forecast in the US 2017-2028: Revenue ($m), AGR (%), CAGR (%)

Table 7.7 EU Overactive Bladder Therapy Market by Country 2017: Revenue ($m), Market Share (%)

Table 7.8 Overactive Bladder Therapeutic Market Forecast in EU5 Region: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.9 Overactive Bladder Therapeutic Market by EU Region: Market Share Forecast 2018-2028 (%)

Table 7.10 Overactive Bladder Therapeutic Market Forecast by EU5 Region:

Table 7.11 Overactive Bladder Therapeutic Market Forecast by EU5 Region: AGR (%) -2017-2028

Table 7.12 Overactive Bladder Therapeutic Market Forecast in the UK: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.13 Overactive Bladder Therapeutic Market Forecast in Germany: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.14 Overactive Bladder Therapeutic Market Forecast in France: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.15 Overactive Bladder Therapeutic Market Forecast in Italy: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.16 Overactive Bladder Therapeutic Market Forecast in Spain: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.17 Overactive Bladder Therapeutic Market Forecast in BRIC Region: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.18 Overactive Bladder Therapeutic Market Forecast in Brazil Region: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.19 Overactive Bladder Therapeutic Market Forecast in Russia: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.20 Overactive Bladder Therapeutic Market Forecast in China: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.21 Overactive Bladder Therapeutic Market Forecast in India: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.22 Overactive Bladder Therapeutic Market Forecast in Japan: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.23 Overactive Bladder Therapeutic Market Forecast in Australia: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 7.24 Overactive Bladder Therapeutic Market Forecast in Canada: Revenue ($m), AGR (%), CAGR (%), 2017-2028

Table 8.1 Astellas: Company Overview

Table 8.2 Pfizer: Company Overview

Table 8.3 Sanofi: Company Overview

Table 8.4 Medtronic: Company Overview

Table 8.5 Medtronic Revenue FY2013 – FY2017

Table 8.6 Medtronic: Urological and Urogynecological Products

Table 8.7 Apotex: Company Overview

Table 8.8 Mylan: Company Overview

Table 9.1 Drugs to Treat Overactive Bladder

Table 10.1 HTA Agencies

Table 11.1 Other Prominent Vendors

List of Figures

Figure 2.1 Prevalence of Overactive Bladder Syndrome versus Other Health Conditions

Figure 2.2 Sales ($m) of Toviaz 2016 versus 2017

Figure 3.1 Global Overactive Bladder Therapeutic Market 2017-2028: Revenue ($m), AGR (%)

Figure 4.1 Global Market Segmentation by Prescription and OTC Drugs, Revenue 2017 ($m)

Figure 4.2 Global Market Segmentation by Prescription and OTC Drugs, Revenue 2017 (%)

Figure 4.3 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs 2017-2028: Revenue ($m)

Figure 4.4 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs, Market share 2017 (%)

Figure 4.5 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs 2017, 2023 and 2028: Revenue ($m)

Figure 4.6 Global Overactive Bladder Therapeutic Market Segmentation by Prescription and OTC Drugs 2017-2028: AGR (%)

Figure 4.7 Global Overactive Bladder Prescription Drugs Market 2017-2028: Revenue ($m), AGR (%)

Figure 4.8 Global Overactive Bladder OTC Drugs Market 2017-2028: Revenue ($m), AGR (%)

Figure 4.9 Global Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2018-2028: Market Share (%)

Figure 4.10 Global Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2017 (%)

Figure 4.11 Global Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2023 (%)

Figure 4.12 Global Overactive Bladder Therapeutic market by Prescription vs OTC Drugs 2028 (%)

Figure 5.1 Global Overactive Drugs Market Segmentation by Duration of Therapy, Revenue 2017 ($m)

Figure 5.2 Global Overactive Drugs Market Segmentation by Duration of Therapy, Revenue 2017 (%)

Figure 5.3 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy 2017-2028: Revenue ($m)

Figure 5.4 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy: Revenue ($m) 2017 and 2028

Figure 5.5 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy 2017-2028: AGR (%)

Figure 5.6 Global Overactive Bladder Short-term Therapy Market 2017-2028: Revenue ($m), AGR (%)

Figure 5.7 Global Overactive Bladder Long-term Therapy Market 2017-2028: Revenue ($m), AGR (%)

Figure 5.8 Global Overactive Bladder Therapeutic Market by Duration of Therapy 2017: Market Share (%)

Figure 5.9 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy, Market Share Forecast 2017, 2023, 2028 (%)

Figure 5.10 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy, Market Share Forecast 2017 (%)

Figure 5.11 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy, Market Share Forecast 2023 (%)

Figure 5.12 Global Overactive Bladder Therapeutic Market Segmentation by Duration of Therapy, Market Share Forecast 2028 (%)

Figure 6.1 Trends in Global Overactive Bladder Therapeutic Market

Figure 6.2 Trends in Global Overactive Bladder Therapeutic Market

Figure 7.1 Global Overactive Bladder Therapeutic Market Segmentation by Region/Country

Figure 7.2 Global Overactive Bladder Therapeutic Market by Region: Revenue ($m)

Figure 7.3 Global Overactive Bladder Therapeutic Market by Region: Market Share 2017 (%)

Figure 7.4 Global Overactive Bladder Therapeutic Market by Country: Revenue ($m)

Figure 7.5 Global Overactive Bladder Therapeutic Market by Country: Market Share (%)

Figure 7.6 Global Overactive Bladder Therapeutic Market Forecast by Region: Revenue ($m), 2017-2028

Figure 7.7 Global Overactive Bladder Therapeutic Market Forecast by Region 2017, 2023, 2028: Revenue ($m)

Figure 7.8 Global Overactive Bladder Therapeutic Market by Region: AGR 2017-2028 (%)

Figure 7.9 Global Overactive Bladder Therapeutic Market Forecast 2017-2028: AGR (%)

Figure 7.10 Global Overactive Bladder Therapeutic Market Share Forecast 2018 (%)

Figure 7.11 Global Overactive Bladder Therapeutic Market Share Forecast 2023 (%)

Figure 7.12 Global Overactive Bladder Therapeutic Market Share Forecast 2028 (%)

Figure 7.13 Overactive Bladder Therapeutic Market in the US: Market Share (%), 2017

Figure 7.14 Overactive Bladder Therapeutic Market Forecast in the US 2017-2028: Revenue ($m), AGR (%)

Figure 7.15 Overactive Bladder Therapeutic Market in the EU5 2017: Global Market Share (%)

Figure 7.16 Overactive Bladder Therapeutic Market in the EU5 Countries 2016: Market Share (%)

Figure 7.17 Overactive Bladder Therapeutic Market Forecast in the EU5 2017-2028: Revenue ($m), AGR (%)

Figure 7.18 Overactive Bladder Therapeutic Market Forecast in EU5 Region: Revenue 2017-2028: Revenue ($m)

Figure 7.19 Overactive Bladder Therapeutic Market Forecast in the EU5 Countries 2017 and 2028: Revenue ($m)

Figure 7.20 Overactive Bladder Therapeutic Market by EU5 Region: Market Share Forecast 2018-2028 (%)

Figure 7.21 Overactive Bladder Therapeutic Market in the EU5 2028: Global Market Share (%)

Figure 7.22 Overactive Bladder Therapeutic Market Forecast by EU5 Region: Market Share 2017(%)

Figure 7.23 Overactive Bladder Therapeutic Market Forecast by EU5 Region: Market Share 2023 (%)

Figure 7.24 Overactive Bladder Therapeutic Market Forecast by EU5 Region: Market Share 2028 (%)

Figure 7.25 Overactive Bladder Therapeutic Market Forecast by EU5 Region

Figure 7.26 Overactive Bladder Therapeutic Market Forecast by EU5 Region: AGR 2017-2028 (%)

Figure 7.27 Overactive Bladder Therapeutic Market Forecast in the UK: Revenue ($m), AGR (%), 2017-2028

Figure 7.28 Overactive Bladder Therapeutic Market Forecast in Germany: Revenue ($m), AGR (%), 2017-2028

Figure 7.29 Overactive Bladder Therapeutic Market Forecast in France: Revenue ($m), AGR (%), 2017-2028

Figure 7.30 Overactive Bladder Therapeutic Market Forecast in Italy: Revenue ($m), AGR (%), 2017-2028

Figure 7.31 Overactive Bladder Therapeutic Market Forecast in Spain: Revenue ($m), AGR (%), 2017-2028

Figure 7.32 Overactive Bladder Therapeutic Market Forecast in the BRIC Countries 2017-2028: Revenue ($m)

Figure 7.33 Overactive Bladder Therapeutic Market Forecast in the BRIC Countries: Revenue ($m) 2017, 2013 and 2028:

Figure 7.34 Overactive Bladder Therapeutic Market Forecast by BRIC Region: Global Market Share 2017(%)

Figure 7.35 Overactive Bladder Therapeutic Market Forecast by BRIC Region: Market Share 2017 (%)

Figure 7.36 Overactive Bladder Therapeutic Market Forecast by BRIC Region: Market Share 2028 (%)

Figure 7.37 Overactive Bladder Therapeutic Market Forecast by BRIC Region: Global Market Share 2028(%)

Figure 7.38 Overactive Bladder Therapeutic Market Forecast in Brazil: Revenue ($m), AGR (%), 2017-2028

Figure 7.39 Overactive Bladder Therapeutic Market Forecast in Russia: Revenue ($m), AGR (%), 2017-2028

Figure 7.40 Overactive Bladder Therapeutic Market Forecast in China: Revenue ($m), AGR (%), 2017-2028

Figure 7.41 Overactive Bladder Therapeutic Market Forecast in India: Revenue ($m), AGR (%), 2017-2028

Figure 7.42 Overactive Bladder Therapeutic Market in Japan: 2017 Revenue ($m), Market Share %

Figure 7.43 Overactive Bladder Therapeutic Market Forecast in Japan: Revenue ($m), AGR (%), 2017-2028

Figure 7.44 Overactive Bladder Therapeutic Market in Australia: 2017 Revenue ($m), Market Share %

Figure 7.45 Overactive Bladder Therapeutic Market Forecast in Australia: Revenue ($m), AGR (%), 2017-2028

Figure 7.46 Overactive Bladder Therapeutic Market in Canada: 2017 Revenue ($m), Market Share %

Figure 8.1 Astellas Sales by Geographic area, Market Share (%), 2017

Figure 8.2 Astellas Sales by Therapeutic area, Market Share (%), 2017

Figure 8.3 Astellas: SWOT Analysis

Figure 8.4 Sales of Pfizer by Geographical region

Figure 8.5 Pfizer: SWOT Analysis

Figure 8.6 Allergan: SWOT Analysis

Figure 8.7 Sanofi: SWOT Analysis

Figure 8.8 Medtronic: SWOT Analysis

Figure 8.9 Apotex: SWOT Analysis

Figure 8.10 A: SWOT Analysis

Figure 10.1: Global Overactive Bladder Therapeutic Market: SWOT Analysis

Figure 10.2: Global Overactive Bladder Therapeutic Market: Porter’s Five Forces Analysis

Figure 12.1 Global Overactive Bladder Therapeutic Market Forecast 2017-2028: Revenue ($m), AGR (%)

Figure 12. 2 Global Overactive Bladder Therapeutic Market by Region: Market Share 2017 (%)

Figure 12.3 Prevalence of Overactive Bladder Syndrome versus Other Major Health Condition

Addex Therapeutics

Allergan

AltheRx Pharmaceuticals

American Oriental Bioengineering

Amerifit

Antares Pharma

Apogepha Arzneimittel

Apotex

Astellas

Aventis

Bayer

Boehringer Ingelheim

Catalent Pharma Solutions

CSL

Eli Lilly

Endo international

FemmePharma

Ferring Pharmaceuticals

Galen Ltd

Hisamitsu Pharmaceutical

Hydra Biosciences

Ion Channel Innovations

Janssen

Kissei Pharmaceutical Co., Ltd.

Kwang Dong Pharmaceutical

KYORIN Pharma

Lipella Pharmaceuticals

Matrix Laboratories Limited

Medtronic

Merck KGaA

Merus Labs Luxco S.a.R.L.

Mylan

Novartis

Ono Pharmaceuticals

Paddock Laboratories

Paladin

Pfizer

Ranbaxy Laboratories

Recordati Pharmaceuticals Ltd

Sanofi

Sanofi Espoir Foundation

Sanofi Synthelabo

Schwarz Pharma AG

Speciality European Pharma Ltd

Warner Chilcott

Watson Pharmaceuticals, Inc.

Yamanouchi Pharma

List of Organisations Mentioned in the Report

Agência Nacional de Vigilância Sanitária (ANVISA)

Canadian Agency for Drugs and Technologies in Health (CADTH)

Gemeinsamer Bundesausschuss (G-BA)

Haute Autorité de santé (HAS)

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWIG)

International Continence Society

Japan Pharmaceutical and Medical Devices Agency (PMDA)

Medicare

Ministry of Health, Labor and Welfare (MHLW)

National Institute for Health and Care Excellence (NICE)

Pharmaceutical Benefits Advisory Committee (PBAC)

Scottish Medicines Consortium (SMC)

The American Urological Association

US Food and Drug Administration (FDA)

World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for Global Overactive Bladder Treatment Market 2018-2028

Download sample pages

Complete the form below to download your free sample pages for Global Overactive Bladder Treatment Market 2018-2028

Case studies

Need customized work?

Report overview

Methodology

Client testimonials

Pharmaceutical industry associations

American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Connect with us

Visiongain Pharma

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.

29 September 2023

READ

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.

27 September 2023

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.

25 September 2023

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.

21 September 2023

READ

Industries > Pharma > Global Overactive Bladder Treatment Market 2018-2028

Back to Pharma Reports

Global Overactive Bladder Treatment Market 2018-2028

Prescription Drugs, OTC Drugs, Short-term Therapy, Long-term Therapy

Download sample pages

Related reports

Global Parkinson’s Disease Drug Market Forecast 2018-2028

Global Anaesthesia Drugs Market 2018-2028

Global Neurostimulation Devices Market 2019-2029

Global Alzheimer’s Disease Therapeutics and Diagnostics Market 2018-2028

Global Medical Device Contract Manufacturing Market Forecast 2018-2028

Download sample pages

Share

Connect with us

Latest Pharma news

Visiongain Publishes Bioreactors Market Report 2023-2033

Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033

Visiongain Publishes Anti-infective Vaccines Market Report 2023-2033

Our Clients